Tokyo-based Astellas Pharma Global Development has appointed Claire Thom senior vice president of global oncology development.

Thom has more than 24 years of experience in the pharmaceutical industry across a range of functional areas, including drug development, new product planning and marketing. Most recently, she was senior vice president, portfolio management, drug development management and strategic business operations at Millennium: The Takeda Oncology Company.